未登录 分享 收藏
分享 收藏
CFHR3*B Haplotype, Complement Activation, and Risk of IgA Nephropathy CFHR3*B单倍型、补体激活和IgA肾病的风险 Zhang, Yongji; Zou, Honghong; Ni, Xinran; Tie, Fenghong; Xu, Boyang; Kang, Yuqi; Xiang, Weiyi; Li, Yaxin; Jia, Changhao; Tan, Ying; Liu, Lijun; Lv, Jicheng; Xiao, Junyu; Xu, Gaosi; Yu, Lei; Zhao, Minghui; Zhu, Li; Zhang, Hong 分享 收藏
分享 收藏
Autosomal dominant tubulointerstitial kidney disease in Chinese patients 常染色体显性小管间质性肾脏病在中国患者中 Li, Meng-shi; Jiang, Lei; You, Rui-lian; Liu, Zhi-ying; Li, Yang; Wang, Xin; Song, Zhuo-ran; Wang, Bin; Chen, Yu-qing; Lv, Ji-cheng; Yang, Li; Zhang, Hong; Zhou, Xu-jie 分享 收藏
C-INSIGHT: design and methodology of a nationwide registry for high-risk chronic kidney disease in China - a study protocol Wang, Guihua; Bian, Xueyan; Luo, Qun; Dong, Junwu; Chen, Wenli; Hao, Yan; Wang, Liang; Xu, Guangbiao; Yi, Bin; Liao, Xiaohui; Chen, Chaosheng; Niu, Jianying; Deng, Jin; Chen, Lianhua; Zhang, Yunfang; Zhou, Tianbiao; Li, Guisen; Zhang, Dongliang; Li, Yi; Mao, Huijuan; Lv, Jicheng; Peng, Qingfeng; Zhang, Chenli; Xiang, Peng; Zhang, Junfei; Li, Hang; Xiao, Yan; Liu, Bicheng 分享 收藏
分享 收藏
分享 收藏
Sex differences across treatment response to corticosteroids and kidney outcomes in IgA nephropathy: insights from the TESTING trial 糖皮质激素治疗反应及肾脏结局的性别差异:TESTING试验的启示 Kim, Dana; Woodward, Mark; Lv, Jicheng; Hladunewich, Michelle; Jha, Vivekanand; Hooi, Lai Seong; Monaghan, Helen; Perkovic, Vlado; Zhang, Hong; Wong, Muh Geot 分享 收藏
分享 收藏
分享 收藏
分享 收藏
分享 收藏
分享 收藏
分享 收藏
分享 收藏
Association of urinary LIF levels with disease prognosis and treatment response to methylprednisolone in IgA nephropathy 尿LIF水平与IgA肾病的疾病预后及甲泼尼龙治疗反应的关系 Zhang, Lei; Dong, Yaping; Xie, Liling; Zhou, Chun; Xu, Linlin; Chao, Shanshan; An, Yacong; Zhang, Hong; Lv, Jicheng; Zhou, Xujie; Nie, Jing 分享 收藏
分享 收藏
分享 收藏
分享 收藏